Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry

OBJECTIVES: To study the number of patients that taper or discontinue concomitant methotrexate (MTX) in daily practice in patients with rheumatoid arthritis (RA) treated with tumour necrosis factor inhibitor (TNFi) and to analyse the effects of that adaption on disease activity and drug survival. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Manders, Sofie H M, van de Laar, Mart A F J, Rongen-van Dartel, Sanne A A, Bos, Reinhard, Visser, Henk, Brus, Herman L, Jansen, Tim, Vonkeman, Harald E, van Riel, Piet L C M, Kievit, Wietske
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623370/
https://www.ncbi.nlm.nih.gov/pubmed/26535151
http://dx.doi.org/10.1136/rmdopen-2015-000147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623370/
https://www.ncbi.nlm.nih.gov/pubmed/26535151
http://dx.doi.org/10.1136/rmdopen-2015-000147

Ejemplares similares